Rights and permissions
About this article
Cite this article
IFN-α-2b maintenance therapy not favoured in multiple myeloma. Pharmacoecon. Outcomes News 142, 5 (1997). https://doi.org/10.1007/BF03272274
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03272274